117 related articles for article (PubMed ID: 8549386)
1. Comparative study of efficacy and safety of ciprofloxacin and cefixime in the treatment of acute exacerbations of chronic bronchitis after first-line treatment failure. French Study Group.
Nouvet G; Benmessaoud K
Drugs; 1995; 49 Suppl 2():423-5. PubMed ID: 8549386
[No Abstract] [Full Text] [Related]
2. Comparative evaluation of the clinical and microbiological efficacy of co-amoxiclav vs cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis.
Cazzola M; Vinciguerra A; Beghi GF; Paizis G; Giura R; Madonini V; Fiorentini F; Consigli GF; Tonna M; Casalini A
J Chemother; 1995 Oct; 7(5):432-41. PubMed ID: 8596127
[TBL] [Abstract][Full Text] [Related]
3. [Cefixime in the treatment of lower respiratory tract infections in patients with chronic bronchitis].
Marcos Sánchez F; Reinoso Cobo D; García Camba L; Celdrán Gil JL
An Med Interna; 1995 Mar; 12(3):150-1. PubMed ID: 7795125
[No Abstract] [Full Text] [Related]
4. Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
Chodosh S; Schreurs A; Siami G; Barkman HW; Anzueto A; Shan M; Moesker H; Stack T; Kowalsky S
Clin Infect Dis; 1998 Oct; 27(4):730-8. PubMed ID: 9798025
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
Chodosh S; McCarty J; Farkas S; Drehobl M; Tosiello R; Shan M; Aneiro L; Kowalsky S
Clin Infect Dis; 1998 Oct; 27(4):722-9. PubMed ID: 9798024
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of twice-daily ciprofloxacin 750 mg in the treatment of patients with acute exacerbations of chronic bronchitis and pneumonia.
Pryka R; Kowalsky S; Haverstock D
Clin Ther; 1998; 20(1):141-55. PubMed ID: 9522111
[TBL] [Abstract][Full Text] [Related]
7. A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group.
Grossman R; Mukherjee J; Vaughan D; Eastwood C; Cook R; LaForge J; Lampron N
Chest; 1998 Jan; 113(1):131-41. PubMed ID: 9440580
[TBL] [Abstract][Full Text] [Related]
8. [Cefixime therapy in sinusitis].
Jorde W; Schata M
Infection; 1990; 18 Suppl 3():S129-31. PubMed ID: 2079372
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 5-day and 10-day cefixime in the treatment of acute exacerbation of chronic bronchitis.
Lorenz J
Chemotherapy; 1998 Sep; 44 Suppl 1():15-8. PubMed ID: 9797418
[TBL] [Abstract][Full Text] [Related]
10. A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies.
Wilton LV; Pearce GL; Mann RD
Br J Clin Pharmacol; 1996 Apr; 41(4):277-84. PubMed ID: 8730972
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cefixime in the treatment of bacterial maxillary sinusitis.
Matthews BL; Kohut RI; Edelstein DR; Rybak LP; Rapp M; McCaffrey TV; Kimmelman CP; Parnes SM; Marinaccio AT; Kohlbrenner VM
South Med J; 1993 Mar; 86(3):329-33. PubMed ID: 8451674
[TBL] [Abstract][Full Text] [Related]
12. [Cefixime therapy in patients with proven gonorrhea].
Backhaus A; Tinzl J
Infection; 1990; 18 Suppl 3():S145-6. PubMed ID: 2079375
[TBL] [Abstract][Full Text] [Related]
13. [The role of ciprofloxacin in the treatment of chronic bronchitis].
Zuck P
Presse Med; 1998 Mar; 27(12):594-6. PubMed ID: 9767959
[No Abstract] [Full Text] [Related]
14. [Efficacy and tolerability of cefixime in lower respiratory tract infections in adults. French multicentric study].
Modai J
Presse Med; 1989 Oct; 18(32):1605-7. PubMed ID: 2530543
[TBL] [Abstract][Full Text] [Related]
15. [Treatment results using cefixime for bacterial respiratory tract infections].
Leonhardt L
Infection; 1990; 18 Suppl 3():S115-8. PubMed ID: 2079368
[TBL] [Abstract][Full Text] [Related]
16. [Clinical efficacy of cefixime (results of multicenter trials)].
Sereda EV; Gusel' VA; Feshchenko IuI; Ustinovich AK; Zubovich VK; Trofimov VI; Nedostup AV; Ovchinnikov IuM; Pluzhnikov MS; Darenkov AF
Antibiot Khimioter; 1993 Jun; 38(6):45-50. PubMed ID: 8166566
[TBL] [Abstract][Full Text] [Related]
17. Quinolone antimicrobial agents in acute exacerbations of chronic bronchitis.
Maesen FP; Davies BI; Teengs JP; Baur C
Eur J Respir Dis Suppl; 1986; 146():585-90. PubMed ID: 3465584
[No Abstract] [Full Text] [Related]
18. Oral treatment of gonorrhea and chlamydia.
Loughlin KA; Bakst CM; Rybak MJ
Ann Pharmacother; 1994 May; 28(5):600-2. PubMed ID: 8068998
[No Abstract] [Full Text] [Related]
19. [Effectiveness and tolerance of cefixime in bacterial infections in the ENT area].
Theopold M; Benner U; Bauernfeind A
Infection; 1990; 18 Suppl 3():S122-4. PubMed ID: 2079370
[TBL] [Abstract][Full Text] [Related]
20. Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis.
Destache CJ; Dewan N; O'Donohue WJ; Campbell JC; Angelillo VA
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():107-13. PubMed ID: 10225580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
